Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Will Mull Lifting Nutritive-Value Requirement For Functional Food Claims

This article was originally published in The Tan Sheet

Executive Summary

FDA will weigh the possibility of a "functional foods" regulatory scheme that expands the range of claims available to conventional food marketers, according to FDA General Counsel Sheldon Bradshaw

You may also be interested in...



FDA Public Meeting Will Explore Regulatory Options For Functional Foods

A distinct regulatory scheme for "functional foods" could benefit both industry and consumers, according to some analysts

Supplement Labeling Safety One Of Six Guidance Topics Raised By GAO

FDA should determine what type of safety information is required on dietary supplement and functional food labeling and release a guidance on the issue, the General Accounting Office states in a July 11 report. The GAO document also identifies five other issues pertaining to dietary supplements and functional foods where FDA guidances are needed.

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel